gsk organizational presentaion

FTSE 100 COMPANY - GLAXOSMITHKLINE 1

GlaxoSmithKline

Presented by:-

Mr. Muhammad Ismail

Mr. Mohsin Yaseen Mr.Abdus Sammad

Mr. Shahid

Mr . khizar Ali

Mr. Anil Kishore

TABLE OF CONTENT

Acnowledgement Introducation Comapny Profile Executive Summary Mission , Values and Strategy history of GSK Gsk Products Management Level Gsk Organizational chart Performance Key Achievement Communication System Conclusion Reference

3

Acnowledgement

4

– First of all we would like to thank Almighty ALLAHA ,without His help we would not able to accomplish this task.

– It would not be possible for us to accomplish this task without the help of many individuals .We would like to thank our instructor of his course (Org Business Communication) Sir Mozzam Shere ,who cooperated with us in the case of quires and confusion .we have tried to fullest to fulfill the requirement of the project that was assigned to us

– Sincerely Muhammad Ismail (10477) Abdu's Samad (10475) Mohsin Yaseen(10452) Khizar Ali (10521) Shahid (10520) Anil Kishore (10461)

Introducation

5

GSK, is a global pharmaceutical, biological, vaccines and consumer healthcare company. It is the world's Six largest pharmaceutical company measured by revenues (after Johnson & Johnson, Pfizer & Roche

Company Profile :- Headquarter LONDON , UK Employee strength 96500 Global operating countries over 206 countries

GSK was formed in 2000 by the merger of GlaxoWellcome plc (formed from the acquisition of Wellcome plc by Glaxo plc), and SmithKline Beecham plc (from the merger of Beecham plc, and SmithKlineBeckman Corporation).

In Pakistan

6

GlaxoSmithKline Pakistan Limited came into existence after the merger of Smith Kline and French of Pakistan Limited and Beecham Pakistan (Private) Limited with Glaxo Wellcome Pakistan Limited in 2002. It is listed on the Karachi and Lahore stock exchanges. GSK has a large portfolio of products ranging tablets, toothpaste, inhalers and complex capsules in over 28,000 different pack sizes and presentations.

HISTORY

7

GSK AT A GLANCE

Executive Summary

Chairman: Sir Christopher Gent

Chief Executive Officer: Andrew Witty

Pakistan Chief Executive Officer: Salman Burney


GSK MISSION


GSK VISION


GSK Values


Respect for People

We believe that respecting each other is the key to

progress and growth for our business, employees and

customers. Our employment practices are designed to

create a culture, in which all GSK employees feel valued,

empowered and inspired to achieve our goals

Patient Focused

Our commitment to our purpose of improving the lives

of billions ensures that all our efforts, be it research,

manufacturing or distribution are geared towards

improving patient access to quality health solutions.

Transparency

As our business evolves to meet global challenges,

so do our existing systems for which transparency is

integral. By being transparent about what we do and

how, we earn and build trust.

Integrity

Our guiding principles go beyond complying with legal

and ethical regulations. Each member of the GSK family

takes pride in doing what is right for the patients and

consumers, placing them at the heart of every decision

we make. In doing so, we demonstrate integrity in action,

at every level, every day.

STRATEGIC PRIORITIES


We are focused on the delivery of five strategic priorities toachieve our mission of helping people “Do more, feel better,live longer.”Everyone at GSK has a role to play in delivering ourstrategic priorities:

Grow a diversified, global business

Deliver more products of value

Create a culture of individual empowerment

Simplify the operating model

Building trust

GSK PRODUCTS


GSK Vaccines


CONSUMER HEALTHCARE PRODUCTS


Management Level:

– The management levels of GSK are as follows:-– Executive-Level– Director-Level – Manager-Level – Staff


GSK Organizational Chart


Board of Directors

Chairmain & CEO

Deputchairman

Executive Directors

Marketing Management Dept.

Strategic Management Dept.

Product Management Dept.

Human Resource Dept.

Selection & Recruitment Dept.

Finance Department

Audit Dept.

Quality Controle Dept.

Product Line Q.C. Dept

Product Q.C. Dept

Sales Management Dept.

National Sales Dept.

Proviosional Salels Dept.

Area Sales Dept.

Trade Net Dept.

International Trade Ins.

General Administration Dept.

Planning & Finance Dept.

Overseas & Domestic Branch office

Advisory Committee on Administration Development


The economic environment in Pakistan witnessed some signs of recovery in 2014, however many key challenges including the security situation, energy shortages &government revenues remain formidable. The recent fall in global energy prices is expected to have a positive impact on the economy and further strengthen growth and reduce inflation in 2015.

During 2014, net sales of your Company were recorded at Rs 27.9 billion with double digit growth. Your Company’s pharmaceutical business segment showed resilience by maintaining market share in the industry and delivered net sales of Rs 23.0 billion reflecting a steady growth of 9.4% over last year. Key portfolios contributing towards this growth were Eye/ear, Anti-Virals, Dermatological, Anthelmentics, Anti-Diarrhoeals, Cough/ Cold and Respiratory. The Consumer Health Care set also evidenced strong growth of 16.3% achieving an overall turnover of Rs 4.9 billion during 2014gmen. Sensodyne, Panadol and Horlicks were the key growth drivers. During the year certain brands were realigned within business segments in line with global strategy, which will help these products achieve bettergrowth and market penetration in the longer term

Performance

AWARDS FOR THE YEAR 2014


Best Corporate Report AwardGSK Pakistan was awarded Certificate of Merit for

“Best Corporate Report Award 2013” in the Other/

Miscellaneous Sector. This award was presented

to GSK by The Joint Committee of The Institute of

Chartered Accountants of Pakistan (ICAP) and the

Institute of Cost and Management Accountants of

Pakistan (ICMAP). This award has been instrumental in

encouraging local companies to follow transparency in

preparing their annual reports according to international

best practices.

Environment Excellence AwardGSK Pakistan has been awarded “11th Annual EnvironmentExcellence Award 2014” by the National Forum forEnvironment and Health (NFEH). The award was givenon its outstanding contribution towards sustainabledevelopment and in protecting the environment for “Cleaner& Greener Pakistan”. GSK was also given a specialrecognition as an “Exemplary Leader TOP 10”.

SWOT ANALYSIS OF GSK PAKISTAN


strength Threat

Weakness Oppotunity

SWOT ANALYSIS OF GSK PAKISTAN


Strengths:Strong

Management Team

Large Market Share

Highest research Products in

PakistanWide range of

Products

Threats:Lower cost

competitors or imports like Chinese and Indian medicines

etcPatent expiry on

drugs that generate strong income

Increasing cost of drug trials (research)

and ever higher standards imposed

by national drug approvals bodies. Weaknesses:

No online presence in

PakistanStrong focus on

UK market (losing opportunities in

Pakistan)Less checking on

the sales representatives for their working

in field

Opportunities:Emerging markets

and expansion abroad

Have great chance to cash its brand name in the field

of surgical marketGSK can be able to cash its name

in baby foods

PORTER’S STRATEGIES THE FIVE FORCES THAT SHAPE INDUSTRY COMPITITION


RIVALARY

AMONG EXISTI

NG COMPITITOR

Planning application in gsk

– TO GROW A DIVERSIFIED GLOBAL BUSINESS.

– DELIVER VALUE PRODUCTS

– SIMPLIFYING THE OPERATING MODEL

– CHALLENGING AND INSPIRING MISSION

– LONG TERM INCENTIVE PLAN


TO GROW A DIVERSIFIED GLOBAL BUSINESS

Increase growth in the pharmaceutical business in its core market.

GSK is diversifying its business to bring balance in product portfolio & go away from a reliance on traditional markets.

GSK expects to generate future sales growth by strengthening its core pharmaceutical business & supplementing it with increased investment in growth such as; vaccines, dermatology and consumer health care.

Business expansion inn JapanBuild a leadership in dermatology.


Deliver value products

Focusing on the best science

Focus on research and development

Diversifying the level of externalization in research to focus on disease area, where GSK believe the prospects for successful registration and launch of differentiated medicines.


SIMPLIFYING THE OPERATING MODEL

As GSK continue to change shape, so it is essential that reduce the complexities in operating model, improve efficiencies and reduce cost.

Re-shape manufacturing


CHALLANGING AND ASPRING MISSION

GSK has a challenging vision and mission is to improve the quality of human life by making people to do more, feel better and live longer.


CHALLANGING AND ASPRING MISSION

Long term incentive plan. awards are made to executives under the following long

term incentive plan, i) Deferred annual bonus planii) Performance share plan

Explanation: Deferred Annual bonus plan: The deferred annual bonus plan encourages long

term shareholding, discourages excessive risk taking and help focus on GSK’S key strategic priorities


GlaxoSmithKline is the best world research pharmaceutical organization with high level combination of resources & skills that provides strong growth in today fast change healthcare environment market .

GlaxoSmithKline are manufacturing ,developing and marketing of pharmaceutical and consumer health related products

GlaxoSmithKline’s has board of pharmaceutical product line includes antibiotics, antidepressant ,gastrointestinal, dermatological ,respiratory ,cancer and cardiovascular medications

GlaxoSmithKline’s has wide variety of vaccine products including hepatitis A and B ,diphtheria taunts and whooping cough and influenza

Bring oral healthcare ,over –the-counter medicines and nutritional healthcare products to millions of people.

In one sentence we can say that Gsk mission is to improve the quality of human life by enabling people to

do more, feel better and live longer


CONCLUSION

REFERENCE

GSK annual report 2014.

www.gsk.com

Wikipedia,2014
